Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
01/31/2002 | WO2002008169A1 Ruthenium complexes and their use in asymmetric hydrogenation |
01/31/2002 | US20020013354 p38 map kinase inhibitors |
01/31/2002 | US20020013322 Novel compounds for enhancing chemotherapy |
01/31/2002 | US20020013317 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease |
01/31/2002 | US20020013316 Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
01/31/2002 | US20020013296 Treating with agonists at kappa opioid receptors such as methyl-4-(2-glycyl-4-(trifluoromethylphenyl)acetyl)-3-(R,S)-((1 -pyrrolidinyl)-methyl)-1-piperazinecarboxylate |
01/31/2002 | CA2416870A1 Potassium channel inhibitors |
01/31/2002 | CA2415738A1 Ruthenium complexes and their use in asymmetric hydrogenation |
01/31/2002 | CA2415606A1 Capsaicin receptor ligands |
01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
01/30/2002 | EP0907634B1 Pesticides |
01/30/2002 | CN1333754A Benzoheterocycles and their use as MEK inhibitors |
01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
01/30/2002 | CN1333207A Sparfloxacin salt and synthesis method and use thereof |
01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
01/24/2002 | WO2002005822A2 Compositions containing therapeutically active components having enhanced solubility |
01/24/2002 | WO2002005819A1 Compounds and methods |
01/24/2002 | US20020010185 Anticarcinogenic agents |
01/24/2002 | US20020010182 Treatment of respiratory diseases such as asthma, bronchitis, rhinitis, cough, expectoration, ophthalmic diseases such as conjunctivitis, dermatitis |
01/24/2002 | US20020009650 High electroconductivity |
01/24/2002 | DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis |
01/23/2002 | EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
01/22/2002 | US6340758 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
01/22/2002 | US6340682 Diamide compound and drugs containing the same |
01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
01/17/2002 | US20020007064 For prevention of psychotic disorders such as schizophrenia and other central nervous system diseases |
01/17/2002 | US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders |
01/17/2002 | US20020006929 Antiarrhythmia agent, antiproliferative agent |
01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
01/17/2002 | CA2415086A1 7,8 and 9-substituted tetracycline compounds |
01/15/2002 | US6339156 Synthesis of piperazine ring |
01/15/2002 | US6339046 Pyrazde herbicides |
01/10/2002 | WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS |
01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
01/10/2002 | US20020004503 Viricides |
01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
01/10/2002 | CA2413241A1 Thrombin or factor xa inhibitors |
01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
01/09/2002 | EP1169312A2 Glucokinase activators |
01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
01/09/2002 | CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
01/09/2002 | CN1330063A Propanedione derivative and use as polymerized ultraviolet absorber |
01/08/2002 | US6337423 Bind to voltage-gated sodium ion channels to modulate activity |
01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
01/03/2002 | WO2002000606A1 Biphenyl compound |
01/03/2002 | WO2002000586A1 The novel propanedione derivatives and their use as polymerizable uv-absorbent |
01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
01/03/2002 | US20020002281 Method of preparing amino carboxylic acids |
01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
01/02/2002 | EP1165545A1 Novel compounds |
01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
01/01/2002 | US6335356 Method of treating a patient by parenteral administration of a lipophilic compound |
01/01/2002 | US6335337 Substituted piperazinones and their therapeutic uses |
12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
12/27/2001 | US20010055960 Rf receiver having cascaded filters and an intermediate amplifier stage |
12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
12/25/2001 | US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases |
12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
12/20/2001 | WO2001095858A2 Piperazinedione compounds |
12/20/2001 | WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same |
12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
12/19/2001 | EP1163237A1 Amide derivatives |
12/19/2001 | EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives |
12/19/2001 | CN1076346C Process for producing aromatic or heteroaromatic sulfur compounds |
12/18/2001 | US6331640 Diaminopropionic acid derivatives |
12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
12/18/2001 | US6331629 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands |
12/18/2001 | US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases |
12/18/2001 | US6331542 Protease inhibitors |
12/18/2001 | CA2166470C Pharmacologically active enantiomers |
12/13/2001 | WO2001094359A1 Chiral ligands for asymmetric catalysis |
12/13/2001 | WO2001025219A3 Piperazine compounds |
12/13/2001 | US20010051630 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses |
12/13/2001 | CA2410410A1 Chiral ligands for asymmetric catalysis |
12/12/2001 | EP1161242A1 Composition and method for treating diabetes |
12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
12/12/2001 | EP0968175B1 Spiro compounds and the use thereof |
12/12/2001 | CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts |
12/12/2001 | CN1326114A Image element containing closed compounds for taking pictures |
12/12/2001 | CN1325685A Mixtures separated from seeds of syzygium, preparations thereof, and uses as medicines containing them and components therefrom |
12/11/2001 | US6329525 High affinity for mitochondrial diazepam binding inhibitor receptor (mdr); anxiolytic agents, side effect reduction |
12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
12/11/2001 | US6329389 Amine compounds, their production and use |
12/11/2001 | US6329378 Heterocyclic fungicides and antigrowth agents |
12/11/2001 | US6329372 Phenylalanine derivatives |
12/11/2001 | CA1341325C Triazole antifungal agents |
12/06/2001 | WO2001092228A2 Process for the synthesis of amine ethers from secondary amino oxides |
12/06/2001 | WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof |
12/06/2001 | US20010049440 Process for preparing Cis-2,6-dimethylpiperazine |